Prognostic significance of non-obstructive left main (LM) disease was recently reported. However, the influence of diabetes mellitus (DM) on event rates in patients with and without non-obstructive LM disease is not well-known.
We evaluated 27,252 patients undergoing coronary computed tomographic angiography from the COroNary CT Angiography Evaluation For Clinical Outcomes: An InteRnational Multicenter (CONFIRM) Registry. Cumulative long-term incidence of all-cause mortality (ACM) was assessed between DM and non-DM patients by normal or non-obstructive LM disease (1–49% stenosis).
The mean age of the study population was 57.612.6 years. Of the 27,252 patients, 4,434 (16%) patients had DM. A total of 899 (3%) deaths occurred during the follow-up of 3.6±1.9. years. Compared to patients with normal LM, those with non-obstructive LM had more pronounced overall coronary atherosclerosis and more cardiovascular risk factors. After clinical risk factors, segment involvement score, and stenosis severity adjustment, compared to patients without DM and normal LM, patients with DM were associated with increased ACM regardless of normal (HR 1.48, 95% CI 1.22–1.78, p<0.001) or non-obstructive LM (HR 1.46, 95% CI 1.04–2.04, p=0.029), while nonobstructive LM disease was not associated with increased ACM in patients without DM (HR 0.85, 95% CI 0.67–1.07, p=0.165) and there was no significant interaction between DM and LM status (HR 1.03, 95% CI 0.69–1.54, p=0.879).
From the CONFIRM registry, we demonstrated that DM was associated with increased ACM. However, the presence of non-obstructive LM was not an independent risk marker of ACM, and there was no significant interaction between DM and non-obstructive LM disease for ACM.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart, Lung and Circulation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.N Engl J Med. 1998; 339: 229-234
- Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey.Diabetes Care. 2005; 28: 1588-1593
- Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes): an InteRnational Multicenter Registry.Diabetes Care. 2012; 35: 1787-1794
- Natural history of diabetic coronary atherosclerosis by quantitative measurement of serial coronary computed tomographic angiography: results of the PARADIGM Study.JACC Cardiovasc Imaging. 2018; 11: 1461-1471
- Prognostic significance of nonobstructive left main coronary artery disease in women versus men: long-term outcomes from the CONFIRM (Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter) Registry.Circ Cardiovasc Imaging. 2017; 10: e006246
- Impact of Non-obstructive left main disease on the progression of coronary artery disease: a PARADIGM substudy.J Cardiovasc Comput Tomogr. 2018; 12: 231-237
- Rationale and design of the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter) Registry.J Cardiovasc Comput Tomogr. 2011; 5: 84-92
- Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts.BMJ. 2012; 344: e3485
- ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology.J Am Coll Cardiol. 2006; 48: 1475-1497
- ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.Circulation. 2010; 121: 2509-2543
- SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography.J Cardiovasc Comput Tomogr. 2009; 3: 122-136
- Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality.J Am Coll Cardiol. 2007; 50: 1161-1170
- Prognostic value of coronary computed tomography angiography in patients with diabetes: a meta-analysis.Diabetes Care. 2016; 39: 1274-1280
- Excess mortality among persons with type 2 diabetes.N Engl J Med. 2015; 373: 1720-1732
- Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: a propensity-score matching study.Atherosclerosis. 2016; 255: 73-79
- Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials.J Am Coll Cardiol. 2008; 52: 255-262
- Angiographically silent left main disease detected by intravascular ultrasound: a marker for future adverse cardiac events.Am Heart J. 2003; 146: 507-512
- International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: rationale and design.Am Heart J. 2018; 201: 124-135
- Changes in medical therapy and lifestyle after anatomical or functional testing for coronary artery disease.J Am Heart Assoc. 2016; 5
- Guiding therapy by coronary CT angiography improves outcomes in patients with stable chest pain.J Am Coll Cardiol. 2019; 74: 2058-2070
- Coronary CT angiography and 5-year risk of myocardial infarction.N Engl J Med. 2018; 379: 924-933
- Outcomes of anatomical versus functional testing for coronary artery disease.N Engl J Med. 2015; 372: 1291-1300
- Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the “warranty period” for remaining normal?.J Am Coll Cardiol. 2010; 55: 1110-1117
- Progression of coronary artery calcium predicts all-cause mortality.JACC Cardiovasc Imaging. 2010; 3: 1229-1236
- Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers.J Am Coll Cardiol. 2007; 50: 2218-2225
- Does vascular calcification accelerate inflammation?: a substudy of the dal-PLAQUE Trial.J Am Coll Cardiol. 2016; 67: 69-78
Published online: November 03, 2022
Accepted: September 9, 2022
Received in revised form: August 21, 2022
Received: May 14, 2022
© 2022 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.